만성 B형 간염 상담: 국내 인터넷 상의 흔한 오류를 중심으로

키워드

참고문헌 (52)

1. "국민건강영양조사 제3기(2005) 검진조사 In: 국민건강영양조사", pp.68~69 (2005), 보건복지부 질병관리본부
2. "나라 B형간염 표면항원 양성률(%). In: 질병관리본부 백서", pp.145~ (2006), 질병관리본부
3. 이선영, "소아의 만성 B형 간염: 새로운 병리조직학적 분류와 임상 소견의 상관 분석", 대한소아소화기영양학회지, 1, pp.56~78 (1998)
4. 최병호, "소아 만성 B형 간염의 관리와 치료", 소아과, 50(9), pp.823~834 (2007), 대한소아과학회
5. Desmet VJ., "Immunopathology of chronic viral hepatitis", Hepatogastroenterology, 38, pp.14~21 (1991)
6. Hsu YS, "Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B", Hepatology, 35, pp.1522~1527 (2002)
7. Lok AS, "Chronic hepatitis B.", Hepatology, 34, pp.1225~1241 (2001)
8. Hui CK, "Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase", Hepatology, 46, pp.395~401 (2007)
9. 정환국, "B형 급성 및 만성간염이 간경변으로 이행하는 병리조직학적 양상", 대한간학회지, 2, pp.134~144 (1996)
10. Yim HJ, "Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005", Hepatology, 43, pp.173~181 (2006)
11. Bortolotti F, "Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study", Hepatology, 43, pp.556~562 (2006)
12. Zacharakis G, "Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece", J Pediatr Gastroenterol Nutr, 44, pp.84~91 (2007)
13. Hsu HY, "Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan", J Med Virol, 18, pp.301~307 (1986)
14. Hsu HY, "Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection", Hepatology, 15, pp.382~386 (1992)
15. 김유리아, "소아의 만성 B형 간염의 자연 경과", 소아과, 47(3), pp.282~289 (2004), 대한소아과학회
16. 최병호, "소아 만성 B형 간염의 관리", In: 2003년 추계 소화기연관학회 합동세미나, pp.250~61 (2003), 대한소화기학회
17. Godra A, "Histopathology of the liver in children with chronic hepatitis B", Mod Pathol, 18, pp.346~ (2005)
18. Hsu HC, "Pathology of chronic hepatitis B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens", Hepatology, 8, pp.378~382 (1988)
19. Bortolotti F, "Ciravegna B, Armigliato M, et al. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood", J Pediatr, 108, pp.224~227 (1986)
20. Hsu HC, "Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis", J Hepatol, 5, pp.260~267 (1987)
21. Chu CM, "Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels", Am J Med, 116, pp.829~34 (2004)
22. 최병호, "B형 간염 바이러스: 발병기전, 분자의학적 진단, 돌연변이의 임상적 의의", 대한소아소화기영양학회지, 10, pp.51~65 (2007)
23. Hadziyannis SJ, "Hepatitis B e antigen- negative chronic hepatitis B", Hepatology, 34, pp.617~624 (2001)
24. Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", Jama, 295, pp.65~73 (2006)
25. 홍경표, "HBsAg 및 antiHBs 검출에 있어서 EIA 법과 RPHA 법 및 PHA 법의 비교", 대한소화기학회지, 19, pp.129~33 (1987)
26. Choe BH, "Lamivudine treatment in children with chronic hepatitis B: long-term therapeutic response, optimal duration and resistance", Proceeding of the 39th Annual Meeting of ESPGHAN; 2006, pp.47~ (2006)
27. Perrillo RP, "Treatment of chronic hepatitis B with interferon: experience in western countries", Semin Liver Dis, 9, pp.240~248 (1989)
28. 박능화, "만성 B형 간질환 환자에서 라미부딘의 치료 효과 및 예측인자", 대한소화기학회지, 42(4), pp.303~312 (2003), 대한소화기학회
29. Choe BH, "Long-term therapeutic efficacy of lamivudine compared to interferon-alpha in children with chronic hepatitis B: the younger the better", J Pediatr Gastroenterol Nutr, 44, pp.92~98 (2007)
30. Liaw YF, "Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update", Liver Int, 25, pp.472~489 (2005)
31. "2007년 대한간학회 만성 B형간염 치료 가이드라인. In: 만성 B형간염 치료 가이드라인" (2007), 대한간학회
32. Mommeja-Marin H, "Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature", Hepatology, 37, pp.1309~1319 (2003)
33. Hartman C, "Long-term lamivudine therapy for chronic hepatitis B infection in children unresponsive to interferon", J Pediatr Gastroenterol Nutr, 43, pp.494~498 (2006)
34. 홍성필, "만성 B형 간질환 환자에서 라미부딘의 장기 치료 효과와 치료 반응의 지속성", 대한간학회지, 7, pp.423~431 (2001)
35. Moraleda G, "Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus", J Virol, 71, pp.9392~9399 (1997)
36. Choe BH, "Predictors of therapeutic response and resistance by long-term follow-up in lamivudine treated children and adolescence with chronic hepatitis B", Proceeding of the 18th conference of Asian Pacific Association for the Study of the Liver, pp.0168~ (2007)
37. 최병호, "소아의 B형 만성 활동성 간염에서 저용량 alfa-interferon과 thymodulin의 병용 치료 효과", 대한소아소화기영양학회지, 1, pp.79~89 (1998)
38. Lee SD, "Role of caesarean section in prevention of mother- infant transmission of hepatitis B virus", Lancet, 2, pp.833~834 (1988)
39. Wang J, "Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis", Chin Med J, 115, pp.1510~1512 (2002)
40. Ohto H, "Intrauterine transmission of hepatitis B virus is closely related to placental leakage", J Med Virol, 21, pp.1~6 (1987)
41. Xu DZ, "Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study", J Med Virol, 67, pp.20~26 (2002)
42. Hill JB, "Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers", Obstet Gynecol, 99, pp.1049~1052 (2002)
43. Wang JS, "Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers", Int J Clin Pract, 57, pp.100~102 (2003)
44. 대한소아과학회, "B형 간염. In: 예방접종지침서. 제5판", pp.48~60 (2002), 대한소아과학회
45. Wei Y, "Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses", J Virol, 70, pp.6455~6458 (1996)
46. Hepatitis B, "Red book: 2006 report of the committee on infectious diseases. 27th ed In: Committee on Infectious Diseases", American Academy of Pediatrics, pp.335~355 (2006)
47. Yuen MF, "Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children", Hepatology, 29, pp.924~927 (1999)
48. Wainwright RB, "Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study", J Infect Dis, 175, pp.674~677 (1997)
49. Lu CY, "Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination", Hepatology, 40, pp.1415~1420 (2004)
50. 최병호, "B형 간염 백신: 주산기 감염 예방과 무반응자 대책", 대한소아소화기영양학회지, 10, pp.91~100 (2007)
51. Alper CA, "Genetic prediction of nonresponse to hepatitis B vaccine", N Engl J Med, 321, pp.708~712 (1989)
52. "Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)", MMWR Recomm Rep, 40, pp.1~25 (1991)

관련 논문AI추천